Author:
Gramer G.,Garbade S. F.,Blau N.,Lindner M.
Subject
Genetics(clinical),Genetics
Reference13 articles.
1. Blau N (2006) Differenzialdiagnose der Hyperphenylalaninämien. Screening auf angeborene Stoffwechselkrankheiten. Kinder- und Jugendmedizin 6: 225–232.
2. Bélanger-Quintana A, Garcia MJ, Castro M, et al (2005) Spanish BH4-responsive phenylalanine hydroxylase-deficient patients: Evolution of seven patients on long-term treatment with tetrahydrobiopterin. Mol Genet Metab 86: S61–66. doi: 10.1016/j.ymgme.2005.07.024 .
3. Fiege B, Blau N (2006) Pharmacokinetics of tetrahydrobiopterin in humans and rats. In: Blau N, ed. PKU and BH 4 , Advances in Phenylketonuria and Tetrahydrobiopterin. Heilbronn: SPS Verlagsgesellschaft, 638–651.
4. Fiege B, Ballhausen D, Kierat L, et al (2004) Plasma tetrahydrobiopterin and its pharmacokinetics following oral administration. Mol Genet Metab 81: 45–51. doi: 10.1016/j.ymgme.2003.09.014 .
5. Levy HL, Milanowski A, Chakrapani A, et al (2007) Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study. Lancet 370(9586): 504–510. doi: 10.1016/S0140-6736(07)61234-3 .
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献